Spindle Cell

A spindle cell is a long, thin, tapered cell that looks elongated and pointed under the microscope, somewhat like a sewing spindle. In cancer, spindle-shaped cells are a defining feature of sarcomatoid tumors, including the sarcomatoid type of mesothelioma. Their appearance contrasts with the rounder, more uniform epithelioid cells seen in other tumor subtypes.

Origin

The term comes from the Old English "spinel," referring to the tapered wooden rod used in hand-spinning thread. Pathologists adopted it in the 19th century to describe elongated cells with pointed ends, and it has been used in cancer classification ever since.

Significance in Asbestos Context

When a pathology report on a mesothelioma biopsy describes "spindle cells," it usually points to either the sarcomatoid subtype or the sarcomatoid component of a biphasic (mixed) mesothelioma. This matters because sarcomatoid mesothelioma typically responds less well to chemotherapy and surgery than the epithelioid subtype, and the prognosis tends to be more guarded. The proportion of spindle cells versus epithelioid cells in a biphasic tumor often influences treatment decisions, eligibility for surgical procedures like pleurectomy or extrapleural pneumonectomy, and enrollment in clinical trials. Spindle-cell findings also require careful immunohistochemistry to distinguish mesothelioma from other spindle-cell tumors such as sarcomas or sarcomatoid carcinomas, which directly affects diagnosis and, in turn, any asbestos-related legal claim.

Example Sentence

The pathology report described a biphasic mesothelioma with approximately 40% spindle cell component, which the oncologist explained would shape the treatment plan and surgical options.

Related Terms

Sarcomatoid Mesothelioma, Biphasic Mesothelioma, Epithelioid Mesothelioma, Immunohistochemistry, Desmoplastic Mesothelioma, Histology

Notes

• Ask your pathologist or oncologist what percentage of the tumor is spindle-cell (sarcomatoid) versus epithelioid, since this ratio affects prognosis and treatment eligibility.
• Request that immunohistochemical stains (such as calretinin, WT-1, cytokeratin, and CK5/6) be performed to confirm mesothelioma rather than another spindle-cell cancer.
• Consider seeking a second pathology opinion from a mesothelioma specialty center, as spindle-cell tumors can be difficult to classify and misdiagnosis is not uncommon.
• Keep complete copies of pathology reports, slides, and tissue blocks. These are critical both for treatment planning and for any future legal claim involving asbestos exposure.